Piramal Pharma Limited

PPLPHARMA NSE Healthcare Pharmaceuticals
Nifty 500 Smallcap 50 Smallcap 100 Smallcap 250
₹211.50
-0.47%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 17 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.